Hyperthyroidism diagnosis and management of graves’ disease

Nurse Practitioner

Volumn 22, Issue 6, 1997, Pages 72-97

  Schilling, Judith S ^a  

^a EDINBORO UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE;

ADULT; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; MIDDLE AGED; NURSING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PHYSIOLOGY; PREGNANCY; REVIEW; THYROID GLAND;

ADULT; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PREGNANCY; THYROID GLAND;

EID: 0031160151     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/00006205-199706000-00005     Document Type: Article

References (28)

1. Franldyn J A.: The management of hyperthyroidism. N Engl J Med 1994; 330(24): 1731-38.
2. Dillman WH: The thyroid. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine, 20th ed. Philadelphia: WB Saunders, 1996: 1227-45.
3. Gill GN: Principles of endocrinology. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine, 20th ed. Philadelphia: VVB Saunders, 1996:1176-85.
4. Guyton AC: Textbook of Medical Physiology, 8th ed. Philadelphia: WB Saunders, 1991:831-41.
5. Siminoski K: Docs this patient have a goiter? JAMA 1995;273(10):813-17.
6. Oertel JE, LiVolsi VA: Pathology of thyroid disease. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:603-42.
7. Larsen PR, Ingbar SH: The thyroid gland. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology, 8th ed. Philadelphia: W.B. Saunders, 1992:357-487.
8. Farid NR: Genetic factors in thyroid disease. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:588-602.
9. Volpc R: Graves’ disease pathogenesis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:648-57.
10. Loeb JN: Metabolic changes in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:845-53.
11. Spaulding SW: Hyperthyroidism systemic cffccts and differential diagnosis. In: Falk SA, ed. Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. New York: Raven Press Ltd, 1990:187-95.
12. Dillman WH: The cardiovascular system and thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:759-70.
13. Delong GR, Adams RD: The neuromuscular system and brain in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991: 793-802.
14. Whybrow PC: Behavioral and psychiatric aspects of thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:863-70.
15. Utiger RD: Disorders of the thyroid gland. In: Kelley WN, ed. Text book of Internal Medicine, 2nd ed. Philadelphia: J.B. Lippincott, 1992:1992-2001.
16. Gorman CA, Bahn RS, Garrity JA: Graves disease ophthalmopathy. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:657-76.
17. Rosen CE, Burdc RM: Pathophysiology and etiology of Graves ophthalmopathy. In: Falk SA, ed. Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. New York: Raven Press Ltd, 1990:255-62.
18. Levy EG: Thyroid disease in the elderly. Med Clin North Am 1991;75(1):151-67.
19. Mechanick JI, Davies TF: Medical management of hyperthyroidism: Theoretical and practical aspects. In: Falk SA, ed. Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. New York: Raven Press Ltd, 1990:197-232.
20. Singer PA, Cooper DS, Levy EG, et al: Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273(10):808-12.
21. Utiger RD: Evaluation of abnormal thyroid function tests. In: Kelley WN, ed. Textbook of Internal Medicine, 2nd ed. Philadelphia: J.B. Lippincott, 1992:2085-89.
22. Hershman JM: The Role of TSI-I Testing in Thyroid Function Assessment. Lincolnshire, III.: Boots Pharmaceuticals, 1994:2-7.
23. Patwardlvan NA, Moront M, Rao S, et al: Surgery still has a role in Graves’ hyperthyroidism. Surgery 1993; 114(6): 1108-13.
24. Soliman M, Kaplan E, Abdel-Latif A, et al: Docs thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients’ T cells to epitopes of thyrotropin rcceptor in autoimmune thyroid disease? J Clin Endocrinol Metal 1995;80(8):2313-21.
25. Watts NB, Blevins LS: Endocrinology. JAMA 1996;275(23): 1806-07.
26. Tallstcdt L, Lundell G, Ton ing O, et al: Occurrence of ophthalmopathy after treatment for Graves’ hyperthyroidism. N Engl J Med 1992;326(26):1733-38.
27. Cooper DS: Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and lngbar’s The Thyroid, 6th ed. Philadelphia: J.B. Lippincott, 1991:887-916.
28. Mclver B, Rae P, Beckett G, ct al: Lack of effect of thyroxine in patients with Graves’ disease hyperthyroidism who are treated with an antithvroid drug. N Engl J Med 1996;334(4):220-24.